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Summary and Implications 
It is estimated that over 50% of all economic losses in 
weaned pigs are due to Escherichia coli infections, causing 
either diarrhea or edema disease.  Despite animal health and 
economic concerns, concerns over the spread of antibiotic 
resistance will limit the types of antibiotics that can be used 
in production animals.  Therefore, we have examined 
alternatives to conventional antibiotics.  
 
Introduction 
With increasing concern over the spread of 
antimicrobial resistance, it is expected that antibiotic use in 
animal feed will become more highly regulated (FDA 
Guidance #78, 1999; #152, 2002), and costly.  This has 
spurred research towards finding alternatives to 
conventional antibiotics for use in the animal feed industry.  
To this end, a great deal of research has been conducted on 
bacteriocins, bacterially-derived proteins with antimicrobial 
activity.  We have examined colicins, a class of bacteriocins 
produced by, and effective against E. coli and closely 
related members of the family Enterobacteriaceae, as 
potential alternatives to conventional antibiotics in animal 
feed.  Colicins have been shown effective against Gram-
negative bacteria, such as E.  coli and Salmonella strains 
(Guterman et al., 1975; Stroud et al., 1998), but have not 
been evaluated for efficacy against E. coli strains 
responsible for post-weaning diarrhea and edema disease.  
In this study, colicins A, E1, and N were selected to provide 
representation of different methods of membrane 
recognition and integration seen among the pore-forming 
colicins (Pugsley, 1987).  These proteins were expressed by 
E. coli and purified by ion exchange chromatography.  Their 
efficacy against E. coli strains responsible for post-weaning 
diarrhea and edema disease (F4 and F18) was determined.  
 
Results and Discussion 
Colicins E1 and N were effective in inhibiting the 
growth of E. coli F4 and F18, whereas Colicin A was not.  A 
dose of 50 µg Colicin E1/mL was needed to inhibit all 
growth of F4 for 6 hours.  A significant reduction in the 
growth of F18 was seen with as little as .25 µg Colicin 
E1/mL of culture, and a complete inhibition of growth for 6 
hours was seen with 1 µg/mL of culture.  Colicin N was 
effective in inhibiting the growth of E. coli F4 (K88) and 
F18 at doses of 1 and 10 µg/mL of culture, respectively.  To 
completely inhibit the growth of both F4 and F18 for 6  
 
 
 
hours required 25 µg of Colicin N/mL of F4 (K88) and 50 
µg/mL of F18.     
Although colicins have great potential as an alternative 
to conventional antibiotics in feed, it would not  
be cost effective to purify this protein from naturally 
occurring colicin producing E. coli strains, or to include the 
levels of these bacteria necessary to obtain an antimicrobial 
effect in the feed.  We are currently examining the use of 
biotechnology to produce these proteins in a more cost-
effective manner.     
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